Literature DB >> 3221257

Effect of interferon-beta on the cell cycle of human glioma cell line U-251 MG: flow cytometric two-dimensional (BrdU/DNA) analysis.

S Genka1, N Shitara, Y Tsujita, Y Kosugi, K Takakura.   

Abstract

This paper describes the determination of the effect of IFN-beta on U-251 MG cells using the bromodeoxyuridine (BrdU/DNA) analysis technique. The cell cycle perturbation of exponentially growing cells was estimated by a newly developed two-dimensional analysis of sequential BrdU/DNA distributions measured at 4-hr intervals after IFN-beta administration. The U-251 MG cell line was sensitive to IFN-beta, and cell proliferation was inhibited by 50.0% at 48 hr. Analysis of DNA histograms indicated that IFN-beta accumulated the cells in the S-phase, from 16 to 48 hr after treatment. In the two-dimensional analysis, labeled cells treated with IFN-beta moved from the S-phase through the G2M-phase and then entered the G1-phase within 12 hr after the initial treatment, in a pattern similar to labeled cells untreated with IFN-beta. After 16 hr, labeled cells treated with IFN-beta began to accumulate in the S-phase and remained there even after 48 hr. These results imply that IFN-beta may have an effect on the G1-phase, thereby inducing S-phase accumulation of human glioma cell line U-251 MG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221257     DOI: 10.1007/bf00177424

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Kinetics of the induction of three translation-regulatory enzymes by interferon.

Authors:  A Kimchi; L Shulman; A Schmidt; Y Chernajovsky; A Fradin; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.

Authors:  K Sasaki; T Murakami; T Ogino; M Takahashi; S Kawasaki
Journal:  Cytometry       Date:  1986-07

3.  Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors:  B Westermark; J Pontén; R Hugosson
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-11

4.  Block of glioma cell line in S by interferon.

Authors:  D Lundblad; E Lundgren
Journal:  Int J Cancer       Date:  1981-06-15       Impact factor: 7.396

Review 5.  [Interferon therapy for malignant brain tumors-present and future (author's transl)].

Authors:  M Nagai; T Arai
Journal:  No Shinkei Geka       Date:  1982-05

6.  Differential effects of pure human alpha and gamma interferons on fibroblast cell growth and the cell cycle.

Authors:  F R Balkwill; A I Bokhon'ko
Journal:  Exp Cell Res       Date:  1984-11       Impact factor: 3.905

7.  [Interferon and its implication for malignant brain tumor].

Authors:  N Shitara; K Takakura; K Sano
Journal:  No Shinkei Geka       Date:  1979-07

8.  Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells.

Authors:  G Roos; T Leanderson; E Lundgren
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

9.  Cytostatic action of human fibroblast interferon in direct growth inhibition: effect on human malignant melanoma.

Authors:  S Nagao; A Tohgo; M Kohno; H Ogawa
Journal:  Gan       Date:  1983-06

10.  Binding of human recombinant 125I-interferon gamma to receptors on human cells.

Authors:  S J Littman; C R Faltynek; C Baglioni
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

View more
  5 in total

1.  Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.

Authors:  A Boiardi; A Silvani; I Milanesi; L Munari; G Broggi; M Botturi
Journal:  Ital J Neurol Sci       Date:  1991-04

2.  Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model.

Authors:  Xiaoyang Ling; Frank Marini; Marina Konopleva; Wendy Schober; Yuexi Shi; Jared Burks; Karen Clise-Dwyer; Rui-Yu Wang; Weiguo Zhang; Xiaoqing Yuan; Hongbo Lu; Lisa Caldwell; Michael Andreeff
Journal:  Cancer Microenviron       Date:  2010-03-19

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 4.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.

Authors:  Y Numa; K Kawamoto; N Sakai; H Matsumura
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.